{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:13:17Z","timestamp":1762272797295,"version":"build-2065373602"},"reference-count":48,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T00:00:00Z","timestamp":1632614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Fragile X syndrome results from the absence of the FMR1 gene product\u2014Fragile X Mental Retardation Protein (FMRP). Fragile X animal research has lacked a reliable method to quantify FMRP. We report the development of an array of FMRP-specific monoclonal antibodies and their application for quantitative assessment of FMRP (qFMRPm) in mouse tissue. To characterize the assay, we determined the normal variability of FMRP expression in four brain structures of six different mouse strains at seven weeks of age. There was a hierarchy of FMRP expression: neocortex &gt; hippocampus &gt; cerebellum &gt; brainstem. The expression of FMRP was highest and least variable in the neocortex, whereas it was most variable in the hippocampus. Male C57Bl\/6J and FVB mice were selected to determine FMRP developmental differences in the brain at 3, 7, 10, and 14 weeks of age. We examined the four structures and found a developmental decline in FMRP expression with age, except for the brainstem where it remained stable. qFMRPm assay of blood had highest values in 3 week old animals and dropped by 2.5-fold with age. Sex differences were not significant. The results establish qFMRPm as a valuable tool due to its ease of methodology, cost effectiveness, and accuracy.<\/jats:p>","DOI":"10.3390\/genes12101516","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T04:55:33Z","timestamp":1632718533000},"page":"1516","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Development of a Quantitative FMRP Assay for Mouse Tissue Applications"],"prefix":"10.3390","volume":"12","author":[{"given":"Tatyana","family":"Adayev","sequence":"first","affiliation":[{"name":"New York State Institute for Basic Research in Developmental Disabilities, New York, NY 10314, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"LaFauci","sequence":"additional","affiliation":[{"name":"New York State Institute for Basic Research in Developmental Disabilities, New York, NY 10314, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Xu","sequence":"additional","affiliation":[{"name":"New York State Institute for Basic Research in Developmental Disabilities, New York, NY 10314, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Dobkin","sequence":"additional","affiliation":[{"name":"New York State Institute for Basic Research in Developmental Disabilities, New York, NY 10314, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Kascsak","sequence":"additional","affiliation":[{"name":"New York State Institute for Basic Research in Developmental Disabilities, New York, NY 10314, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Ted","family":"Brown","sequence":"additional","affiliation":[{"name":"New York State Institute for Basic Research in Developmental Disabilities, New York, NY 10314, USA"},{"name":"Perkins Center, University of Sydney Camperdown, Sydney, NSW 2006, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey H.","family":"Goodman","sequence":"additional","affiliation":[{"name":"New York State Institute for Basic Research in Developmental Disabilities, New York, NY 10314, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,26]]},"reference":[{"key":"ref_1","first-page":"359","article-title":"FMR1 and the Fragile X Syndrome: Human Genome Epidemiology Review","volume":"3","author":"Crawford","year":"2001","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(91)90397-H","article-title":"Identification of a Gene (FMR-1) Containing a CGG Repeat Coincident with a Breakpoint Cluster Region Exhibiting Length Variation in Fragile X Syndrome","volume":"65","author":"Verkerk","year":"1991","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41583-021-00432-0","article-title":"The Molecular Biology of FMRP: New Insights into Fragile X Syndrome","volume":"22","author":"Richter","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(91)90125-I","article-title":"Absence of Expression of the FMR-1 Gene in Fragile X Syndrome","volume":"66","author":"Pieretti","year":"1991","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/hmg\/2.8.1147","article-title":"Fine Structure of the Human FMR1 Gene","volume":"2","author":"Eichler","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/ng0793-244","article-title":"Human and Murine FMR-1: Alternative Splicing and Translational Initiation Downstream of the CGG\u2013Repeat","volume":"4","author":"Ashley","year":"1993","journal-title":"Nat. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/hmg\/2.4.399","article-title":"Alternative Splicing in the Fragile X Gene FMR1","volume":"2","author":"Verkerk","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/hmg\/5.1.95","article-title":"Alternative Splicing of Exon 14 Determines Nuclear or Cytoplasmic Localisation of FMR1 Protein Isoforms","volume":"5","author":"Sittler","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0959-437X(02)00300-3","article-title":"Advances in Understanding of Fragile X Pathogenesis and FMRP Function, and in Identification of X Linked Mental Retardation Genes","volume":"12","author":"Bardoni","year":"2002","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.tig.2017.07.008","article-title":"Multifarious Functions of the Fragile X Mental Retardation Protein","volume":"33","author":"Davis","year":"2017","journal-title":"Trends Genet. TIG"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Maurin, T., and Bardoni, B. (2018). Fragile X Mental Retardation Protein: To Be or Not to Be a Translational Enhancer. Front. Mol. Biosci., 5.","DOI":"10.3389\/fmolb.2018.00113"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ejhg.2016.204","article-title":"Intragenic FMR1 Disease-Causing Variants: A Significant Mutational Mechanism Leading to Fragile-X Syndrome","volume":"25","author":"Quartier","year":"2017","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng0193-31","article-title":"A Point Mutation in the FMR-1 Gene Associated with Fragile X Mental Retardation","volume":"3","author":"Verkerk","year":"1993","journal-title":"Nat. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/ajmg.a.32261","article-title":"Mosaic FMR1 Deletion Causes Fragile X Syndrome and Can Lead to Molecular Misdiagnosis","volume":"146","author":"Coffee","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/1096-8628(200023)97:3<195::AID-AJMG1037>3.0.CO;2-R","article-title":"Transcription of the FMR1 Gene in Individuals with Fragile X Syndrome","volume":"97","author":"Tassone","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1399-0004.2009.01237.x","article-title":"Screening and Instability of FMR1 Alleles in a Prospective Sample of 24,449 Mother\u2013Newborn Pairs from the General Population","volume":"76","author":"Dombrowski","year":"2009","journal-title":"Clin. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/gim.2014.106","article-title":"Fragile X Full Mutation Expansions Are Inhibited by One or More AGG Interruptions in Premutation Carriers","volume":"17","author":"Nolin","year":"2015","journal-title":"Genet. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1086\/302720","article-title":"Elevated Levels of FMR1 MRNA in Carrier Males: A New Mechanism of Involvement in the Fragile-X Syndrome","volume":"66","author":"Tassone","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/hmg\/10.14.1449","article-title":"Reduced FMRP and Increased FMR1 Transcription Is Proportionally Associated with CGG Repeat Number in Intermediate-Length and Premutation Carriers","volume":"10","author":"Kenneson","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1017\/S1355838202020642","article-title":"Reduced FMR1 MRNA Translation Efficiency in Fragile X Patients with Premutations","volume":"8","author":"Primerano","year":"2002","journal-title":"RNA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1021\/ac9008918","article-title":"A Polymerase Chain Reaction, Nuclease Digestion, and Mass Spectrometry Based Assay for the Trinucleotide Repeat Status of the Fragile X Mental Retardation 1 Gene","volume":"81","author":"Dodds","year":"2009","journal-title":"Anal. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/gtmb.2009.0108","article-title":"High-Risk Fragile X Screening in Guatemala: Use of a New Blood Spot Polymerase Chain Reaction Technique","volume":"13","author":"Yuhas","year":"2009","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/gm401","article-title":"FMR1 CGG Allele Size and Prevalence Ascertained through Newborn Screening in the United States","volume":"4","author":"Tassone","year":"2012","journal-title":"Genome Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1373\/clinchem.2006.068593","article-title":"Simplified Molecular Diagnosis of Fragile X Syndrome by Fluorescent Methylation-Specific PCR and GeneScan Analysis","volume":"52","author":"Zhou","year":"2006","journal-title":"Clin. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Gatta, V., Gennaro, E., Franchi, S., Cecconi, M., Antonucci, I., Tommasi, M., Palka, G., Coviello, D., Stuppia, L., and Grasso, M. (2013). MS-MLPA Analysis for FMR1 Gene: Evaluation in a Routine Diagnostic Setting. BMC Med. Genet., 14.","DOI":"10.1186\/1471-2350-14-79"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1373\/clinchem.2013.217331","article-title":"Early Detection of Fragile X Syndrome: Applications of a Novel Approach for Improved Quantitative Methylation Analysis in Venous Blood and Newborn Blood Spots","volume":"60","author":"Inaba","year":"2014","journal-title":"Clin. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1542\/peds.2016-1159F","article-title":"Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment","volume":"139","author":"Kaufmann","year":"2017","journal-title":"Pediatrics"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jmoldx.2013.02.006","article-title":"Fragile X Screening by Quantification of FMRP in Dried Blood Spots by a Luminex Immunoassay","volume":"15","author":"LaFauci","year":"2013","journal-title":"J. Mol. Diagn. JMD"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Adayev, T., LaFauci, G., Dobkin, C., Caggana, M., Wiley, V., Field, M., Wotton, T., Kascsak, R., Nolin, S.L., and Glicksman, A. (2014). Fragile X Protein in Newborn Dried Blood Spots. BMC Med. Genet., 15.","DOI":"10.1186\/s12881-014-0119-0"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"LaFauci, G., Adayev, T., Kascsak, R., and Brown, W. (2016). Detection and Quantification of the Fragile X Mental Retardation Protein 1 (FMRP). Genes, 7.","DOI":"10.3390\/genes7120121"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Budimirovic, D.B., Schlageter, A., Filipovic-Sadic, S., Protic, D.D., Bram, E., Mahone, E.M., Nicholson, K., Culp, K., Javanmardi, K., and Kemppainen, J. (2020). A Genotype-Phenotype Study of High-Resolution FMR1 Nucleic Acid and Protein Analyses in Fragile X Patients with Neurobehavioral Assessments. Brain Sci., 10.","DOI":"10.21203\/rs.3.rs-34874\/v1"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0306-4522(03)00406-8","article-title":"The Fragile x Mental Retardation Protein Binds and Regulates a Novel Class of MRNAs Containing u Rich Target Sequences","volume":"120","author":"Chen","year":"2003","journal-title":"Neuroscience"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1189\/jlb.1106665","article-title":"CpG Oligodeoxynucleotide-Enhanced Humoral Immune Response and Production of Antibodies to Prion Protein PrPSc in Mice Immunized with 139A Scrapie-Associated Fibrils","volume":"81","author":"Spinner","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/08820139709048931","article-title":"Immunodiagnosis of Prion Disease","volume":"26","author":"Kascsak","year":"1997","journal-title":"Immunol. Invest."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"17597","DOI":"10.1074\/jbc.M111101200","article-title":"Dynamin Is a Minibrain Kinase\/Dual Specificity Yak1-Related Kinase 1A Substrate","volume":"277","author":"Chen","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF01721323","article-title":"Structural Aspects of Antibody-Antigen Interaction Revealed through Small Random Peptide Libraries","volume":"1","author":"Slootstra","year":"1996","journal-title":"Mol. Divers."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jmr.846","article-title":"Functional Reconstruction and Synthetic Mimicry of a Conformational Epitope Using CLIPSTM Technology","volume":"20","author":"Timmerman","year":"2007","journal-title":"J. Mol. Recognit."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainres.2014.11.023","article-title":"Expression of Fragile X Mental Retardation Protein in Neurons and Glia of the Developing and Adult Mouse Brain","volume":"1596","author":"Gholizadeh","year":"2015","journal-title":"Brain Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1089\/hum.2016.090","article-title":"FMRP Expression Levels in Mouse Central Nervous System Neurons Determine Behavioral Phenotype","volume":"27","author":"Arsenault","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1101\/gr.2825804","article-title":"An Efficient SNP System for Mouse Genome Scanning and Elucidating Strain Relationships","volume":"14","author":"Petkov","year":"2004","journal-title":"Genome Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0197-4580(99)00044-5","article-title":"Age-Dependent Cerebral Atrophy and Cognitive Dysfunction in SAMP10 Mice","volume":"20","author":"Shimada","year":"1999","journal-title":"Neurobiol. Aging"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.neuropharm.2005.06.004","article-title":"Suppression of Two Major Fragile X Syndrome Mouse Model Phenotypes by the MGluR5 Antagonist MPEP","volume":"49","author":"Yan","year":"2005","journal-title":"Neuropharmacology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1528-1157.2000.tb01499.x","article-title":"Audiogenic Seizures Susceptibility in Transgenic Mice with Fragile X Syndrome","volume":"41","author":"Musumeci","year":"2000","journal-title":"Epilepsia"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.expneurol.2006.08.007","article-title":"Audiogenic Seizure Susceptibility Is Reduced in Fragile X Knockout Mice after Introduction of FMR1 Transgenes","volume":"203","author":"Musumeci","year":"2007","journal-title":"Exp. Neurol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijdevneu.2015.02.004","article-title":"Fragile X Mental Retardation Protein (FMRP) Interacting Proteins Exhibit Different Expression Patterns during Development","volume":"42","author":"Bonaccorso","year":"2015","journal-title":"Int. J. Dev. Neurosci. Off. J. Int. Soc. Dev. Neurosci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/vcp.12314","article-title":"Evaluation of Hematologic Composition in Newborn C57\/BL6 Mice up to Day 35","volume":"45","author":"White","year":"2016","journal-title":"Vet. Clin. Pathol. Am. Soc. Vet. Clin. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ame2.12099","article-title":"Hematological Reference Values and Animal Welfare Parameters of BALB\/C-FMABC (Mus Musculus) Inoculated with Ehrlich Tumor Kept in the Vivarium at ABC Medical School","volume":"3","author":"Sampaio","year":"2020","journal-title":"Anim. Models Exp. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ame2.12139","article-title":"Clinical Hematological and Biochemical Parameters in Swiss, BALB\/c, C57BL\/6 and B6D2F1 Mus Musculus","volume":"3","author":"Bax","year":"2020","journal-title":"Anim. Models Exp. Med."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/12\/10\/1516\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:05:30Z","timestamp":1760166330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/12\/10\/1516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,26]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["genes12101516"],"URL":"https:\/\/doi.org\/10.3390\/genes12101516","relation":{},"ISSN":["2073-4425"],"issn-type":[{"type":"electronic","value":"2073-4425"}],"subject":[],"published":{"date-parts":[[2021,9,26]]}}}